Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May;19(5):510-518.
doi: 10.1111/jch.12958. Epub 2017 Jan 6.

The impact of an individualized risk-adjusted approach on hypertension treatment in primary care

Affiliations

The impact of an individualized risk-adjusted approach on hypertension treatment in primary care

Stefan Zechmann et al. J Clin Hypertens (Greenwich). 2017 May.

Abstract

Previous studies suggest that up to 60% of all patients with hypertension receive inappropriate treatment. Current 2013 European Society of Hypertension/European Society of Cardiology (ESH/ESC) guidelines recommend taking cardiovascular risk factors into account when assessing treatment for patients with hypertension. The authors hypothesize that this approach will reduce the proportion of patients receiving inappropriate treatment. In this cross-sectional study using electronic medical records of Swiss primary care patients, the authors estimate the proportion of patients receiving inappropriate treatment using two approaches: (1) based on a blood pressure threshold of 140/90 mm Hg; and (2) based on cardiovascular risk factors. A total of 22 434 patients with hypertension were identified. Based on these approaches, 72.7% and 44.6% of patients, respectively, qualified for drug treatment. In addition, 23.0% and 10.8% of patients, respectively, received inappropriate treatment. Application of the 2013 ESH/ESC guidelines reduced the proportion of patients receiving inappropriate treatment by 50%. This shows the major impact of risk adjustment and highlights the need for a patient-centered approach in hypertension treatment.

Keywords: antihypertensive therapy; clinical management of high blood pressure; primary care issues; risk assessment; treatment and diagnosis/guidelines.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Stratification of patients. BP, blood pressure; DBP, diastolic blood pressure; SBP, systolic blood pressure; HT, hypertension; CKD, chronic kidney disease; CVD, cardiovascular disease; OD, organ damage; RFs, risk factors
Figure 2
Figure 2
Inclusion flowchart. ATC, Anatomical Therapeutic Chemical Classification System; BP, blood pressure; FIRE, Family Medicine ICPC‐Research Using Electronic Medical Records; ICPC‐2, second version of the International Classification of Primary Care
Figure 3
Figure 3
Patients with hypertension. BP, blood pressure; CI, confidence interval
Figure 4
Figure 4
Age stratification of patients.

Similar articles

Cited by

References

    1. WHO . World Health Organisation. World Health Statistics 2015. http://www.who.int/gho/publications/world_health_statistics/2015/en/. ISBN 978 92 4 069443 9 (PDF).
    1. Patel SA, Winkel M, Ali MK, Narayan KM, Mehta NK. Cardiovascular mortality associated with 5 leading risk factors: national and state preventable fractions estimated from survey data. Ann Intern Med. 2015;163:245–253. - PubMed
    1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217–223. - PubMed
    1. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34:2159–2219. - PubMed
    1. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta‐analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665. - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources